TekniPlex Expands Multidose Packaging Capacity for Pharmaceuticals
Event summary
- TekniPlex Healthcare will showcase expanded multidose packaging capabilities at Pharmapack (Jan. 21-22, 2026).
- Added injection blow molding capacity for 5-30 ml multidose vials at Modena, Italy facility.
- Launched coextruded blown films and bags with oxygen barrier properties at Puurs, Belgium facility.
- Introduced PFAS-free SBC PVDC-coated PVC structures for enhanced barrier protection.
The big picture
TekniPlex's expansion aligns with the pharmaceutical industry's shift toward advanced drug delivery systems and sustainable packaging solutions. The company's focus on regulatory-aligned materials positions it to capitalize on growing demand for high-performance, preservative-free multidose formulations, particularly in the ophthalmic market. This strategic move underscores the increasing importance of materials science in pharmaceutical packaging.
What we're watching
- Market Adoption
- How quickly pharmaceutical companies will integrate TekniPlex's new multidose packaging solutions into their supply chains.
- Regulatory Alignment
- Whether TekniPlex can maintain compliance with evolving pharmaceutical packaging regulations across global markets.
- Competitive Positioning
- The pace at which competitors respond with similar barrier material innovations.
Related topics